Dr. Charles Raymond Shideman, MD, PhD

Dr. Shideman practices at Minneapolis Radiation Oncology PA in Minneapolis, Minnesota.

Dr. Shideman's NPI, 1841466026, was assigned on May 7, 2008. Dr. Shideman graduated from University of Minnesota Medical School in 2007. Dr. Shideman holds Minnesota license 54992.

Dr. Shideman's primary practice is Minneapolis Radiation Oncology PA, at 7401 Metro Blvd, Minneapolis, MN 55439 in Hennepin County. The practice phone is (952) 920-4915.

Dr. Shideman's primary practice is Minneapolis Radiation Oncology PA in Minneapolis, Minnesota. Dr. Shideman is also affiliated with Regions Hospital. The medical group on file is Minneapolis Radiation Oncology. Dmand AI also links Dr. Shideman to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shideman practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Shideman's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Shideman is licensed in Minnesota.

CMS data shows 1,926 Medicare services from Dr. Shideman across 14 procedure codes in 2024, for 183 Medicare patients. Medicare paid $154,654 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 183 Medicare patients who saw Dr. Shideman in 2024. The largest group is 65 to 74, with 103 patients. 75% of them have cancer, and 69% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shideman's median patient age at 69, with 48% women.

In 2024, Dr. Shideman wrote 195 Medicare Part D claims for 87 patients. 98% of them were for generic drugs. CMS names the drug for 139 of them, across 6 drugs with 11 or more claims each, at $1,812 in total drug cost. In 2023, CMS named 80 claims across 4 drugs.

Dr. Shideman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Shideman. Dr. Shideman's most frequent co-authors are Denis Regis Clohisy, MD and Christian M. Ogilvie, MD.

Dmand AI links Dr. Shideman to 4 clinical trials, 2 of them phase 2/3 studies. 4 are still active or recruiting. Conditions studied include Lung Neoplasms, Nasopharyngeal Carcinoma and Nasopharyngeal Diseases. NRG Oncology sponsors the most, 3.

CMS Open Payments shows 1 general payment to Dr. Shideman from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Varian Medical Systems, Inc. paid the most, $14.

Dr. Shideman graduated from University of Minnesota Medical School in 2007.